Cited by 156Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain

Open access
Hammond, Christine J, Hallock, Loretta R, Howanski, Raymond J, Appelt, Denah M, Little, C Scott, Balin, Brian J·2010·BMC Neuroscience

Abstract

Background: Sporadic late-onset Alzheimer's disease (AD) appears to evolve from an interplay between genetic and environmental factors. One environmental factor that continues to be of great interest is that of Chlamydia pneumoniae infection and its association with late-onset disease. Detection of this organism in clinical and autopsy samples has proved challenging using a variety of molecular and histological techniques. Our current investigation utilized immunohistochemistry with a battery of commercially available anti-C. pneumoniae antibodies to determine whether C. pneumoniae was present in areas typically associated with AD neuropathology from 5 AD and 5 non-AD control brains. Results: Immunoreactivity for C. pneumoniae antigens was observed both intracellularly in neurons, neuroglia, endothelial cells, and peri-endothelial cells, and extracellularly in the frontal and temporal cortices of the AD brain with multiple C. pneumoniae-specific antibodies. This immunoreactivity was seen in regions of amyloid deposition as revealed by immunolabeling with two different anti-beta amyloid antibodies. Thioflavin S staining, overlaid with C. pneumoniae immunolabeling, demonstrated no direct co-localization of the organism and amyloid plaques. Further, the specificity of C. pneumoniae labeling of AD brain sections was demonstrated using C. pneumoniae antibodies pre-absorbed against amyloid β 1-40 and 1-42 peptides. Conclusions: Anti-C. pneumoniae antibodies, obtained commercially, identified both typical intracellular and atypical extracellular C. pneumoniae antigens in frontal and temporal cortices of the AD brain. C. pneumoniae, amyloid deposits, and neurofibrillary tangles were present in the same regions of the brain in apposition to one another. Although additional studies are required to conclusively characterize the nature of Chlamydial immunoreactivity in the AD brain, these results further implicate C. pneumoniae infection with the pathogenesis of Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2202-11-121

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C. pneumoniae antigens have been detected inside both astrocytes and microglia in post-mortem human brains.

    “C. pneumoniae antigens have been detected inside both astrocytes and microglia in post-mortem human brains9,11,67,68.”

    From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [67]

    The Results (page not available) report intracellular C. pneumoniae antigen labeling in neuroglia in human Alzheimer’s disease brain tissue. They do not identify the labeled neuroglia separately as both astrocytes and microglia. The Background says those cell types are susceptible to infection, but that does not establish antigen detection inside each in the examined brains. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hammond, C. J., Hallock, L. R., Howanski, R. J., Appelt, D. M., Little, C. S., & Balin, B. J.
Affiliations
Philadelphia College of Osteopathic Medicine (US)
Corresponding author
Balin, Brian J
Venue
BMC Neuroscience
Published
2010-09-23
Volume
11
Issue
1
Pages
121-121
ISSN
1471-2202 (ISSN-L)
OpenAlex
W2056188402
Cited by
156
References
49
Citations by year
2026: 5 · 2025: 11 · 2024: 6 · 2023: 4 · 2022: 21 · 2021: 12 · 2020: 17 · 2019: 11 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 11 · 2013: 11 · 2012: 4
FWCI
4.76
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Drexel University
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Chlamydia pneumoniae, Alzheimer's disease, late-onset Alzheimer's disease, chlamydia, amyloid plaques, amyloid-beta, neurofibrillary tangles, frontal and temporal cortex, antibody specificity, neuroinflammation, Alzheimer's disease pathogenesis
MeSH terms
Aged, Alzheimer Disease, Brain, Brain Chemistry, Cerebral Cortex, Chlamydia Infections, Coloring Agents, Female, Humans, Immunohistochemistry, Male, Thiazoles, Tissue Banks, Reproducibility of Results, Amyloid beta-Peptides, Neurofibrillary Tangles, Chlamydophila pneumoniae, Benzothiazoles, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review